Integra LifeSciences Announces New Leadership
Today, Integra LifeSciences Holdings Corporation (Nasdaq:IART) has made significant news with the appointment of Mojdeh Poul as its new president and chief executive officer. This decision comes from the board of directors as part of an ongoing commitment to leadership and innovation in the medical technology sector.
Leadership Transition at Integra LifeSciences
Mojdeh Poul is set to step into her new role effective January 6, 2025, succeeding Jan De Witte, who will maintain his position as president and CEO until that date. In addition to her new role, Ms. Poul will join the company's board of directors. Stuart Essig will continue as executive chairman for a transitional period before returning to his previous role as non-executive chairman.
Stuart Essig Expresses Enthusiasm
“The board and I are thrilled to welcome Mojdeh as Integra’s next president and CEO,” stated Stuart Essig. He cited her vast experience in global healthcare and her remarkable ability to drive strategic initiatives and commercial excellence. He emphasized that her leadership skills are essential for the successful execution of Integra’s future plans.
Mojdeh Poul's Impressive Background
Before joining Integra LifeSciences, Ms. Poul held a notable position at 3M where she led its Global Healthcare Business, which generated revenues of $8.5 billion. Her responsibilities included overseeing research and development, quality assurance, and regulatory matters. During her tenure, she significantly transformed the healthcare portfolio through strategic acquisitions and innovative product development.
Prior Experience in Leading Companies
Ms. Poul has an extensive track record of success, having held prominent leadership roles at Medtronic and Boston Scientific. Her experience includes accelerating the adoption of new medical technologies across various sectors, particularly in neuromodulation and emerging cardiovascular therapies.
Vision for Integra LifeSciences
In her statement, Ms. Poul expressed her gratitude for the opportunity to lead Integra. She highlighted her focus on operational excellence and quality compliance as key priorities during her transition. Her plan includes maximizing the capabilities of Integra’s robust product portfolio.
Contribution to the Healthcare Sector
Ms. Poul is also an active board member at several esteemed organizations. She serves on the board and audit committee of Align Technology, and she holds similar positions at iRhythm Technologies and Stanley Black and Decker. This repertoire enhances her understanding of the healthcare landscape and positions her well for leading Integra.
Educational Background
Ms. Poul holds both a bachelor’s and master’s degree in mechanical engineering from the University of Louisville, along with an MBA from the University of North Carolina at Chapel Hill. Her academic credentials complement her extensive professional experience, equipping her to guide Integra effectively.
Recognition of Jan De Witte's Contributions
As Ms. Poul prepares to take the helm, Stuart Essig acknowledged Jan De Witte’s leadership and the strategic groundwork he laid during his tenure. His efforts focused on growing the company’s international business and integrating digital technology, marking significant milestones in Integra's history.
A Legacy of Innovation and Commitment
Jan expressed heartfelt thanks to the team at Integra for their dedication, emphasizing the company’s rich history of medical innovations. He believes the passion of Integra’s employees and its technological advancements will drive success far into the future.
About Integra LifeSciences
Integra LifeSciences is committed to restoring patients’ lives through innovative technologies and solutions. With a focus on setting new standards in surgical, neurologic, and regenerative care, the company continues to develop high-quality medical products that cater to a wide range of healthcare needs.
Frequently Asked Questions
Who is the new CEO of Integra LifeSciences?
Mojdeh Poul is the newly appointed CEO of Integra LifeSciences, taking on her role starting January 6, 2025.
What experience does Mojdeh Poul have?
Mojdeh Poul has extensive experience in the healthcare sector, having previously served as the executive vice president at 3M, where she oversaw a significant segment of their healthcare business.
What will Jan De Witte's role be after the transition?
Jan De Witte will continue as president and CEO until the transition date and will then step back to focus on other leadership roles within the company.
How does Integra LifeSciences innovate in healthcare?
Integra LifeSciences is known for its commitment to innovation, focusing on advancing treatment pathways and enhancing patient outcomes through superior product development.
What is Integra's mission?
Integra LifeSciences aims to restore patients’ lives through advanced medical technologies and a robust dedication to quality healthcare.
